OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Emerging Concepts-Advanced Ovarian, Fallopian, Peritoneal, and Cervical Cancers

home / peer-exchange / ovarian-cervical-cancers
Introduction: Molecular Testing in Ovarian Cancer

EP. 1: Introduction: Molecular Testing in Ovarian Cancer

July 2nd 2015
Bevacizumab in Platinum-Resistant Ovarian Cancer

EP. 2: Bevacizumab in Platinum-Resistant Ovarian Cancer

July 2nd 2015
Bevacizumab in Platinum-Sensitive Ovarian Cancer

EP. 3: Bevacizumab in Platinum-Sensitive Ovarian Cancer

July 2nd 2015
Frontline Therapy in Advanced Ovarian Cancer

EP. 4: Frontline Therapy in Advanced Ovarian Cancer

July 2nd 2015
Biomarkers for Bevacizumab in Ovarian Cancer

EP. 5: Biomarkers for Bevacizumab in Ovarian Cancer

July 2nd 2015
Utilizing Olaparib in Ovarian Cancer

EP. 6: Utilizing Olaparib in Ovarian Cancer

July 2nd 2015
Managing Platinum-Resistant Ovarian Cancer

EP. 7: Managing Platinum-Resistant Ovarian Cancer

July 2nd 2015
Bevacizumab in Advanced Cervical Cancer

EP. 8: Bevacizumab in Advanced Cervical Cancer

July 2nd 2015
Carboplatin Versus Cisplatin in Cervical Cancer

EP. 9: Carboplatin Versus Cisplatin in Cervical Cancer

July 2nd 2015
Prevention and Early Detection of Cervical Cancer

EP. 10: Prevention and Early Detection of Cervical Cancer

July 2nd 2015
Treating Locally Advanced Cervical Cancer

EP. 11: Treating Locally Advanced Cervical Cancer

July 2nd 2015
Future of Ovarian and Cervical Cancers

EP. 12: Future of Ovarian and Cervical Cancers

July 2nd 2015

Latest Conference Coverage

Tucatinib/Trastuzumab Yields Durable Responses in HER2-Mutated Metastatic Breast Cancer

T-DM1 Plus Palbociclib Displays Activity in HER2+ Metastatic Breast Cancer

EL1SSAR Data Shed Light on Leveraging Atezolizumab Plus Nab-Paclitaxel in PD-L1+ TNBC

Pretreatment ctDNA Status Is Associated With Distant Recurrent-Free Survival in Early Breast Cancer

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact